Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02834052
Title Pembrolizumab + Poly-ICLC in MRP Colon Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Samir N. Khleif
Indications

colon cancer

Therapies

Pembrolizumab + Poly ICLC

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Georgia Cancer Center at Augusta University Recruiting Augusta Georgia 30912 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field